A protein known as SLAT (SWAP70-like adaptor of T cells) was recently identified, but elucidation of its function awaited further study. Now, reporting in The Journal of Clinical Investigation, Bécart et al. show that SLAT is required for T-cell development, activation and effector function, and it does this by controlling calcium signalling.
SLAT (also known as IBP) is a guanine-nucleotide-exchange factor that is known to be activated following ligation of the T-cell receptor (TCR). To investigate the physiological role of SLAT in T cells, Bécart et al. studied T-cell development in SLAT-deficient mice. Their analysis revealed that there was a defect at an early stage of thymocyte development in Slat−/− mice, such that proliferation of thymocytes at the double negative 1 (DN1) stage was impaired. As a result, fewer CD4+ T cells and, to a lesser extent, CD8+ T cells were present in the periphery of Slat−/− mice compared with wild-type mice.
Moreover, those CD4+ T cells that did populate the periphery in Slat−/− mice showed markedly reduced proliferation and interleukin-2 production in response to TCR and CD28 ligation, although they proliferated normally in response to PMA (phorbol 12-myristate 13-acetate) plus ionomycin (stimuli known to bypass the TCR).
Previous studies had suggested that SLAT might be involved in T helper 2 (TH2)-cell differentiation, so the authors next tested the ability of Slat−/− mice to mount TH2-cell-mediated lung inflammation. As expected, there was a marked reduction in TH2-cell-mediated lung inflammation in Slat−/− mice; unexpectedly, however, Slat−/− mice also failed to mount TH1-cell-mediated lung inflammatory responses, indicating that SLAT is involved in responses by both TH1- and TH2-cell subsets.
Further investigation into the activation defect in T cells from Slat−/− mice indicated that the most marked defect was in the nuclear translocation of NFAT (nuclear factor of activated T cells) following TCR and CD28 stimulation. Consistent with this, the initial rise in the free intracellular Ca2+ concentration that should occur following TCR ligation to promote NFAT translocation was severely reduced in the absence of SLAT. This, the authors show, most likely reflects a defect in the release of Ca2+ from endoplasmic reticulum stores.
So, by controlling TCR-induced Ca2+ and NFAT signalling, SLAT is required for proper T-cell development and effector function.
References
ORIGINAL RESEARCH PAPER
Bécart, S. et al. SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signaling. J. Clin. Invest. 117, 2164–2175 (2007)
FURTHER READING
Feske, S. Calcium signalling in lymphocyte activation and disease. Nature Rev. Immunol. 7, 690–702 (2007)
Rights and permissions
About this article
Cite this article
Bird, L. New regulator of calcium signalling. Nat Rev Immunol 7, 663 (2007). https://doi.org/10.1038/nri2169
Issue Date:
DOI: https://doi.org/10.1038/nri2169